At a glance
ClinicalIndex Comparison RecordN/ACompleted· 75 enrolled
Drug / intervention
progressive muscle relaxationbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effects of Progressive Muscle Relaxation Therapy in Patients With Schizophrenia: Randomized Controlled Trials
In Brief
A clinical study evaluating progressive muscle relaxation for Affective Disorders and Psychotic Disorder. Completed, enrolled 75 participants.
Detailed Summary
This study applied a randomized parallel case-controlled design. The study purpose was to evaluate the effects of progressive muscle relaxation on anxiety, psychiatric symptoms and quality of life among patients with chronic schizophrenia compared with an active control.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAffective Disorders, Psychotic Disorder
Countries--
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJun 2014
Primary CompletionJun 2015
First PostedSep 2018
TodayJul 2026
First PostedSep 12, 2018
Enrollment StartJun 30, 2014
Primary CompletionJun 29, 2015
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 7.8 years ago
Interventions
progressive muscle relaxationbehavioral
intervention group: The experimental group received muscle relaxation training once a week for 3 consecutive months. The results were measured and followed up after 3 months.